Stocks To Buy Today: Brokerage have recommended several stocks to buy for long-term gains. The top picks include Eterna (Zomato), Power Grid, Ather Energy, Global Heal (Medanta) and ICICI Bank. Let's take a look at target price and the rationale behind the investments.
Eternal Share Price Target (Zomato)
Elara Capital has recommended BUY rating on Eternal shares (Zomato). It said that the recent platform fee hike was in line with the company's guidance of achieving adjusted EBITDA in the band of 5-6 per cent. As on Q3FY26, Zomato ’s adjusted EBITDA was at 5.4 per cent, and estimated to reach 6.0 per cent by FY28E. Recently, Eternal hiked the platform fee Rs 15.
Elara Capital has set a target price of Rs 415 on Zomato shares.
ICICI Bank Share Price Target
BP Equities has recommended BUY rating on ICICI Bank shares for a target price of Rs 1,433. The brokerage noted that ICICI Bank is India’s second-largest private sector bank by assets, with a consolidated balance sheet of Rs 27.5 lakh crore as of December 2025. The brokerage said that the Customer 360 initiative continues to improve engagement, driving traction in current accounts and diversified sourcing across salary accounts, transaction banking, and digital channels. Margins are expected to remain stable, supported by disciplined pricing and a balanced loan mix. Operating efficiency also remains intact. The combination of improving credit demand and stable funding supports sustainable earnings visibility.
Power Grid Share Price Target
Elara Capital has maintained BUY rating on Power Grid shares for a target price of Rs 360. Elara said that Power Grid remains a direct beneficiary of the sustained investment upcycle in the power sector. Execution momentum has strengthened, with management upgrading capex target.
Ather Energy Share Price Target
Ambit has initiated coverage on Ather Energy with BUY rating. The brokerage has set a target price of Rs 929 on Ather Energy shares. It said that Ather is transitioning from a high-burn startup to a scalable multi platform manufacturer targeting the 80 er cent ‘convenience’ segment. Its 17 per cent market share is underpinned by introduction of Rizta and a 31 per cent cost reduction fundamentally engineered in-house, insulating it from receding government subsidies.
Global Health Share Price Target (Medanta)
JM Financial has maintained BUY rating on Global Health with a target price of Rs 1,382. The brokerage said that Medanta stock has corrected ~30% over the past six months and ~15% in the last month due to the launch of the Noida greenfield unit and recent geopolitical concerns stemming from the Middle East conflict. The stock is currently trading at 21x FY27E EBITDA, implying a 25% discount to its historical average. However, both the aforementioned factors are transitory and likely to normalise over the coming quarters. The company has limited exposure (~2% of sales) to Middle East patients, which can be offset through incremental domestic demand and inflows from other geographies.
